Display options
Share it on

Endocrinol Diabetes Metab Case Rep. 2018 Jul 21;2018. doi: 10.1530/EDM-18-0068. eCollection 2018.

Brachydactyly mental retardation syndrome with growth hormone deficiency.

Endocrinology, diabetes & metabolism case reports

Alireza Arefzadeh, Pooyan Khalighinejad, Bahar Ataeinia, Pegah Parvar

Affiliations

  1. Endocrinology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  4. School of Medicine, Islamic Azad University Medical Branch of Tehran, Tehran, Iran.

PMID: 30087780 PMCID: PMC6063990 DOI: 10.1530/EDM-18-0068

Abstract

Deletion of chromosome 2q37 results in a rare congenital syndrome known as brachydactyly mental retardation (BDMR) syndrome; a syndrome which has phenotypes similar to Albright hereditary osteodystrophy (AHO) syndrome. In this report, we describe a patient with AHO due to microdeletion in long arm of chromosome 2 [del(2)(q37.3)] who had growth hormone (GH) deficiency, which is a unique feature among reported BDMR cases. This case was presented with shortening of the fourth and fifth metacarpals which along with AHO phenotype, brings pseudopseudohypoparathyroidism (PPHP) and pseudohypoparathyroidism type Ia (PHP-Ia) to mind; however, a genetic study revealed del(2)(q37.3). We recommend clinicians to take BDMR in consideration when they are faced with the features of AHO; although this syndrome is a rare disease, it should be ruled out while diagnosing PPHP or PHP-Ia. Moreover, we recommend evaluation of IGF 1 level and GH stimulation test in patients with BDMR whose height is below the 3rd percentile.

LEARNING POINTS: Clinicians must have brachydactyly mental retardation (BDMR) syndrome in consideration when they are faced with the features of Albright hereditary osteodystrophy.Although BDMR syndrome is a rare disease, it should be ruled out while diagnosing PPHP or PHP-Ia.Evaluation of IGF1 level in patients diagnosed with BDMR whose height is below the 3rd percentile is important.

References

  1. Am J Hum Genet. 1995 Feb;56(2):400-7 - PubMed
  2. J Med Genet. 2006 Jun;43(6):478-89 - PubMed
  3. Eur J Hum Genet. 2013 Jun;21(6):602-12 - PubMed
  4. Am J Hum Genet. 2010 Aug 13;87(2):219-28 - PubMed
  5. Eur J Med Genet. 2007 Jan-Feb;50(1):73-8 - PubMed
  6. J Med Genet. 2004 Jun;41(6):433-9 - PubMed
  7. J Pediatr Endocrinol Metab. 2013;26(7-8):793-5 - PubMed
  8. BMC Med Genomics. 2014 Apr 22;7:19 - PubMed
  9. J Clin Endocrinol Metab. 2010 Nov;95(11):5011-7 - PubMed
  10. J Clin Endocrinol Metab. 2011 Oct;96(10):3020-30 - PubMed
  11. Ann Pediatr Endocrinol Metab. 2017 Jun;22(2):129-132 - PubMed
  12. J Indian Soc Pedod Prev Dent. 2009 Jul-Sep;27(3):184-8 - PubMed
  13. Mol Genet Genomic Med. 2015 Mar;3(2):111-20 - PubMed
  14. Cytogenet Genome Res. 2015;146(1):33-8 - PubMed
  15. Am J Med Genet A. 2004 Nov 1;130A(4):331-9 - PubMed
  16. Eur J Hum Genet. 2013 Jul;21(7):743-8 - PubMed
  17. Am J Med Genet A. 2012 Sep;158A(9):2124-30 - PubMed
  18. Clin Cancer Res. 2009 Oct 1;15(19):5985-92 - PubMed

Publication Types